ArticleMetabolic brain disease2026
Gestational deltamethrin exposure exacerbates post-traumatic epileptiform activity and social deficits, diminishing the therapeutic efficacy of curcumin in rats.
Article in Metabolic brain disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational exposure to the neurotoxic insecticide deltamethrin (DLT) is suspected to increase susceptibility to neurological disorders, but its impact on secondary brain injuries and therapeutic interventions remains poorly understood. This study investigates whether prenatal DLT exposure exacerbates post-traumatic epileptogenesis in offspring and evaluates whether it compromises the neuroprotective efficacy of curcumin. Pregnant rats were exposed to DLT during gestation, and post-traumatic epileptiform activity was subsequently induced in the offspring using a focal FeCl₃ cortical injury model. Following oral curcumin administration, subjects were evaluated utilizing electrocorticography, behavioral assays, Golgi staining, and immunohistochemistry. We found that gestational DLT exposure significantly exacerbated injury pathology, evidenced by heightened neuronal hyperexcitability, severe social behavioral deficits, reduced dendritic complexity, profound loss of synaptic markers (PSD95 and SYP), upregulation of voltage-gated sodium channels (NaV1.1 and NaV1.6), and aggravated glial activation. Crucially, while curcumin treatment successfully attenuated molecular, histological, and electrophysiological pathologies, prior DLT exposure exacerbated the epileptic phenotype and severely interfered with curcumin's overall therapeutic efficacy, preventing absolute cellular markers from fully returning to unexposed recovery levels. Furthermore, prior DLT exposure actively blunted curcumin's ability to rescue complex social behavioral deficits. These findings demonstrate that early-life environmental toxicant exposure increases vulnerability to post-traumatic epileptogenesis and establishes a severely aggravated pathological baseline that limits the overall restorative capacity of subsequent interventions.
Indexed as
Identifiers
42384231What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.